Trending:

Abi Millar

All articles by Abi Millar

  1. Is a lack of female participants skewing heart disease trial results?

    Heart disease is a major health concern for both men and women. According to the British Heart Foundation, there are…
    Read More…

    20 Nov

  2. Using AI to personalise drug combination therapy

    Multiple myeloma is a difficult cancer to treat. A form of blood cancer, it is considered incurable, but the available…
    Read More…

    15 Nov

  3. Manufacturing personalised meds: what needs to change?

    The age of personalised medicine – once discussed in purely hypothetical terms – is now very much upon us. With…
    Read More…

    13 Nov

  4. Cancer trials: making the most of biomarkers

    Over the last two decades, we have seen a surge of targeted treatments for cancer. Beginning with Herceptin (which is…
    Read More…

    5 Nov

  5. Gene and cell therapies: making manufacturing work

    Gene and cell therapies are two of the fastest emerging areas of medicine. Comprising techniques such as gene editing and…
    Read More…

    3 Oct

  6. Cannabinoids breakthrough signals hope for epilepsy treatment

    On 25h June 2018, the US Food and Drug Administration (FDA) approved Epidiolex, a cannabinoid-based medicine for treating seizures in…
    Read More…

    3 Sep

  7. Philanthropy in pharma: a look inside the ISPE Foundation

    In June, the International Society of Pharmaceutical Engineering (ISPE) launched the ISPE Foundation, its philanthropic arm. Funded exclusively through donations,…
    Read More…

    29 Aug

  8. Could cutting out mediators let cancer research off the leash?

    In 2014, Bristol Myers Squibb (BMS) and The University of Texas MD Anderson Cancer Center announced a pioneering research collaboration….
    Read More…

    13 Aug

  9. The next generation of antimalarials

    Over the last two decades, the fight against malaria has been overwhelmingly successful. Between 2000 and 2015, global malaria deaths…
    Read More…

    7 Aug

  10. Paying the bill for innovative gene and cell therapies

    Our new era of precision medicine holds great promise for patients. If therapies can be tailored to their exact needs…
    Read More…

    2 Aug

Go Top